News
An influx of illegal vapes that are appealing to children and teens has been making its way into the U.S. from China, FDA ...
The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according ...
The Food and Drug Administration (FDA) has been busy lately with various recalls. One involved Power Stick deodorant and ...
FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...
Explore more
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results